<?xml version="1.0"?>
<?xml-stylesheet type="text/xsl" href="billres.xsl"?>
<!DOCTYPE bill PUBLIC "-//US Congress//DTDs/bill.dtd//EN" "bill.dtd">
<bill bill-stage="Introduced-in-Senate" dms-id="A1" public-private="public">
	<metadata xmlns:dc="http://purl.org/dc/elements/1.1/">
<dublinCore>
<dc:title>113 S2917 IS: Adding Ebola to the FDA Priority Review Voucher Program Act</dc:title>
<dc:publisher>U.S. Senate</dc:publisher>
<dc:date>2014-11-12</dc:date>
<dc:format>text/xml</dc:format>
<dc:language>EN</dc:language>
<dc:rights>Pursuant to Title 17 Section 105 of the United States Code, this file is not subject to copyright protection and is in the public domain.</dc:rights>
</dublinCore>
</metadata>
<form>
		<distribution-code display="yes">II</distribution-code>
		<congress>113th CONGRESS</congress><session>2d Session</session>
		<legis-num>S. 2917</legis-num>
		<current-chamber>IN THE SENATE OF THE UNITED STATES</current-chamber>
		<action>
			<action-date date="20141112">November 12, 2014</action-date>
			<action-desc><sponsor name-id="S172">Mr. Harkin</sponsor> (for himself, <cosponsor name-id="S289">Mr. Alexander</cosponsor>, <cosponsor name-id="S182">Ms. Mikulski</cosponsor>, <cosponsor name-id="S254">Mr. Enzi</cosponsor>, <cosponsor name-id="S229">Mrs. Murray</cosponsor>, <cosponsor name-id="S300">Mr. Burr</cosponsor>, <cosponsor name-id="S309">Mr. Casey</cosponsor>, <cosponsor name-id="S305">Mr. Isakson</cosponsor>, <cosponsor name-id="S320">Mrs. Hagan</cosponsor>, <cosponsor name-id="S118">Mr. Hatch</cosponsor>, <cosponsor name-id="S332">Mr. Franken</cosponsor>, <cosponsor name-id="S260">Mr. Roberts</cosponsor>, <cosponsor name-id="S330">Mr. Bennet</cosponsor>, <cosponsor name-id="S339">Mr. Kirk</cosponsor>, <cosponsor name-id="S316">Mr. Whitehouse</cosponsor>, <cosponsor name-id="S365">Mr. Scott</cosponsor>, <cosponsor name-id="S354">Ms. Baldwin</cosponsor>, <cosponsor name-id="S364">Mr. Murphy</cosponsor>, <cosponsor name-id="S366">Ms. Warren</cosponsor>, <cosponsor name-id="S311">Ms. Klobuchar</cosponsor>, <cosponsor name-id="S341">Mr. Blumenthal</cosponsor>, <cosponsor name-id="S369">Mr. Markey</cosponsor>, <cosponsor name-id="S307">Mr. Brown</cosponsor>, <cosponsor name-id="S301">Mr. Coburn</cosponsor>, <cosponsor name-id="S252">Ms. Collins</cosponsor>, and <cosponsor name-id="S253">Mr. Durbin</cosponsor>) introduced the following bill; which was read twice and referred to the <committee-name committee-id="SSHR00">Committee on Health, Education, Labor, and Pensions</committee-name></action-desc>
		</action>
		<legis-type>A BILL</legis-type>
		<official-title>To expand the program of priority review to encourage treatments for tropical diseases.  </official-title>
	</form>
	<legis-body>
		<section id="S1" section-type="section-one"><enum>1.</enum><header>Short title</header><text display-inline="no-display-inline">This Act may be cited as the <quote><short-title>Adding Ebola to the FDA Priority Review Voucher Program Act</short-title></quote>.</text></section><section id="id0FB2205E53A34A4B85A62C8391E370CF" section-type="subsequent-section"><enum>2.</enum><header>Priority review to encourage treatments for tropical diseases</header><text display-inline="no-display-inline">Section 524 of the Federal Food, Drug, and Cosmetic Act (<external-xref legal-doc="usc" parsable-cite="usc/21/360n">21 U.S.C. 360n</external-xref>) is amended—</text><paragraph id="idE49BCCB76D8B4A9FAB3630A41EFE8199"><enum>(1)</enum><text>in subsection (a)(3)—</text><subparagraph id="idAA07FBC2ED85428E865A091CE17C5862"><enum>(A)</enum><text>by redesignating subparagraph (Q) as subparagraph (R);</text></subparagraph><subparagraph id="id16A78F9A04DB4C55AB10E3AC20548949"><enum>(B)</enum><text>by inserting after subparagraph (P) the following:</text><quoted-block display-inline="no-display-inline" id="id10673255AEBC4BE3A7DF7D617AE81911" style="OLC"><subparagraph id="id7F814DCACA9B46E993BAD77D0E40A7D4"><enum>(Q)</enum><text>Filoviruses.</text></subparagraph><after-quoted-block>; and</after-quoted-block></quoted-block></subparagraph><subparagraph id="idA3718C1E988343D4952CCF46F5B64EAF"><enum>(C)</enum><text>in subparagraph (R), as so redesignated, by striking <quote>regulation by</quote> and inserting <quote>order of</quote>; and</text></subparagraph></paragraph><paragraph id="idE7874CA2ED7E49C9A4CED53DE1BDA117"><enum>(2)</enum><text>in subsection (b)—</text><subparagraph id="idCCD0528AE3A945F895A04B573AFCC0A4"><enum>(A)</enum><text>in paragraph (2), by adding <quote>There is no limit on the number of times a priority review voucher may be transferred before such
			 voucher is used.</quote> after the period at the end; and</text></subparagraph><subparagraph id="id5AF8FF406045498DA9E2427B97DB741B"><enum>(B)</enum><text>in paragraph (4), by striking <quote>365 days</quote> and inserting <quote>90 days</quote>.</text>
				</subparagraph></paragraph></section></legis-body>
</bill>


